Remote Pharmacy GLP-1 Program 2026: Compounded Semaglutide From $167/Month, No Subscription, No Hidden Fees - Pricing, Process, and What Patients Are Asking
How Remote Pharmacy's Physician-Supervised Telehealth Program Delivers Injectable and Sublingual Compounded Semaglutide and Tirzepatide With No Insurance, No Hidden Fees, and Free Shipping - Plus What the 2026 FDA Regulatory Environment Means for Compounded GLP-1 Access
MIAMI, May 5, 2026 (Newswire.com) - Paid Advertorial Disclosure: This article was produced in connection with a marketing arrangement and contains affiliate links. If a purchase is made through these links, a commission may be earned at no additional cost to the reader.
Medical Disclaimer: This article is for informational purposes only and is not medical advice. Prescription weight management medications require evaluation and a prescription from a licensed healthcare provider. Individual eligibility and results vary.
Compounded Medication Notice: Compounded semaglutide and tirzepatide are not FDA-approved finished drug products, are not generic versions of Ozempic®, Wegovy®, Mounjaro®, or Zepbound®, and have not been reviewed by the FDA for safety, effectiveness, or quality.
Last verified: May 2026. Pricing, availability, and program details reflect information published on remotepharmacy.com at the time of this overview. Patients should confirm current terms directly at remotepharmacy.com before enrolling.
Remote Pharmacy GLP-1 Program 2026: $167/Month Compounded Semaglutide, No Subscription, Same-Day Approval - Full Program Breakdown
If you are comparing telehealth GLP-1 programs and Remote Pharmacy is on your list, this overview will answer five things most articles skip entirely: the exact starting price at each product tier, who the actual prescribing physician group is, which states cannot receive compounded semaglutide, what "no subscription" means in practice, and what the 2026 FDA regulatory environment means for your access before you commit to any program.
The telehealth GLP-1 category is crowded right now. Prices in this space run from under $150 to over $400 per month depending on the platform, the medication, and whether fees are bundled or stacked separately at checkout. Remote Pharmacy's published starting price of $167/month for compounded semaglutide puts it in the more accessible tier of a market where the average compounded program runs closer to $200-$300/month. That pricing is real, verified, and clearly listed on the platform's weight-loss page - not a teaser rate with a hidden consultation fee added later.
According to brand-reported data, Remote Pharmacy has fulfilled more than 18,000 prescriptions since launching its telehealth program. It operates across the continental United States, subject to state-level pharmacy restrictions detailed later in this overview.
Three distinct entities are involved in every Remote Pharmacy treatment: Remote Pharmacy LLC - the technology platform managing intake, patient portal, and shipping logistics - Beluga Health, P.A. c/o Jonah Mink MD - the independent medical group whose licensed U.S. physicians conduct consultations and write prescriptions - and two licensed U.S. compounding pharmacies that prepare and fulfill the medications. Remote Pharmacy itself does not practice medicine and does not dispense drugs. The clinical decision about whether you receive a prescription belongs entirely to the independent physician - not the platform.
One point has to be stated clearly before anything else. The compounded semaglutide and tirzepatide available through Remote Pharmacy are not FDA-approved finished drug products. They are not generic versions of Ozempic®, Wegovy®, Mounjaro®, or Zepbound®, and they are not interchangeable with those branded medications. They are compounded formulations prepared by state-licensed pharmacies that have not been reviewed by the FDA for safety, effectiveness, or quality. That is the foundation for evaluating this program, or any compounded GLP-1 program.
Remote Pharmacy GLP-1 Pricing at a Glance - May 2026
Medication | Starting Price | Format | Dosing | FDA-Approved? |
Compounded Semaglutide - Injectable | $167/month | Subcutaneous injection | Once weekly | No - compounded |
Semaglutide Tablets - Sublingual | $167/month | Under the tongue | Once daily | No - compounded |
Compounded Tirzepatide - Sublingual | $229.99/month | Under the tongue | Once daily | No - compounded |
Tirzepatide Tablets - Sublingual | $229.99/month | Under the tongue | Once daily | No - compounded |
Pricing shown reflects published starting prices on Remote Pharmacy's weight-loss page as of May 2026. Higher dosage tiers cost more. No separate consultation fee, no shipping charge, no membership fee - the published price covers medication, physician consultation, and delivery. Verify current pricing at remotepharmacy.com before enrolling. Remote Pharmacy's homepage references a starting price of $287/month for certain program configurations; confirm which product and tier applies during the intake process.
Note on the FDA-Approved column: Every row reads "No - compounded." That is not a weakness in this table. It is the most important fact in any honest overview of this program, stated where it belongs - at the point of decision, not buried in a disclaimer block at the bottom of the page.
What GLP-1 Medications Are and Why the Mechanism Matters
GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking a natural gut hormone involved in blood sugar regulation, appetite signaling, and the rate at which food leaves the stomach. When GLP-1 receptors are activated, the pancreas releases insulin in response to rising glucose, glucagon secretion is reduced, and gastric emptying slows. The practical effect is a prolonged sense of fullness that tends to reduce overall caloric intake over time.
Semaglutide targets the GLP-1 receptor pathway. Tirzepatide targets two incretin hormone pathways simultaneously - GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). The GIP pathway influences insulin sensitivity and fat metabolism in addition to the appetite effects GLP-1 alone produces. That broader hormonal engagement is reflected in tirzepatide's higher price point across every platform that offers both.
FDA-approved branded GLP-1 medications exist for diabetes management and chronic weight management, including Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. The compounded formulations discussed throughout this article are separate products and should not be treated as FDA-approved, generic, equivalent, or interchangeable versions of those branded medications.
GLP-1 medications are generally indicated for adults with a body mass index above the healthy range or adults with weight-related health conditions. Eligibility is determined by a licensed physician after a clinical assessment - it is not automatic upon enrollment or payment.
What Remote Pharmacy Is - And What It Is Not
Remote Pharmacy is a fully online telehealth platform. No in-person visits at any stage. Its role is to manage patient intake, connect patients to independent licensed physicians, coordinate prescription fulfillment through partner pharmacies, handle shipping, and provide ongoing support through its patient portal and customer care team.
Remote Pharmacy does not diagnose conditions, write prescriptions, or dispense drugs. Those functions belong to the independent medical group and independent pharmacies it works with. The physician who evaluates a patient's case is an independent provider - not a Remote Pharmacy employee. The pharmacy that prepares and ships the medication is independently licensed under state and federal compounding law. Understanding that separation matters because it defines where clinical accountability lives in this model.
The 2026 Regulatory Context: What Every Patient Researching This Program Needs to Know Right Now
The regulatory environment for compounded GLP-1 medications changed materially in 2026, and that shift directly affects patients who are still in the research phase. Here is what it means in practical terms for someone evaluating Remote Pharmacy today.
The FDA has stated that promotional materials for non-FDA-approved compounded GLP-1 products cannot claim those products are generic versions of FDA-approved drugs, use the same active ingredient in a way that implies clinical equivalence, or are clinically proven to produce the same outcomes as branded medications. This overview does not make those claims. Patients should be cautious about any program that does.
As of the FDA's most recent 2026 guidance, semaglutide and tirzepatide do not appear on the 503B bulk substances list or the FDA's drug shortage list. On April 30, 2026, the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list entirely, finding no clinical need for outsourcing facilities to compound those drugs from bulk substances. For 503A pharmacies - the category Remote Pharmacy's partner facilities operate under - prescriptions must be patient-specific and cannot be used to manufacture regular copies of commercially available products at scale.
What this means for a patient enrolling today: availability is subject to change. FDA policy, pharmacy eligibility, state law, and prescription-specific requirements can all affect whether compounded GLP-1 medications remain accessible through any given platform. The era of large-scale 503B bulk GLP-1 compounding has largely closed. Patient-specific 503A compounding by licensed pharmacies with valid individual prescriptions remains legal - but the environment is more closely scrutinized in May 2026 than it was in January 2025.
This applies to every telehealth platform offering compounded GLP-1 medications, not only Remote Pharmacy. Remote Pharmacy's published disclaimers correctly state that its compounded medications are not FDA-approved and have not been reviewed for safety, effectiveness, or quality. Patients should verify that any program they consider makes the same disclosures with equal clarity.
Compounded Semaglutide vs. Compounded Tirzepatide: The Decision Framework
Both are compounded formulations. Neither is FDA-approved. The active ingredients and mechanisms differ, and so does the price.
Semaglutide engages the GLP-1 receptor. Tirzepatide engages both GLP-1 and GIP receptors - a dual-pathway approach that is designed to address insulin sensitivity and fat metabolism alongside appetite regulation. Clinical trials for the FDA-approved branded versions of these medications - not the compounded formulations - have reported significant weight-loss outcomes in specific studied populations when combined with lifestyle modification. Those findings belong to those branded products studied in those trials. They cannot be applied to compounded formulations, which have not been studied in equivalent large-scale trials and have not been reviewed by the FDA for safety, effectiveness, or quality. Individual outcomes vary considerably.
The format difference matters practically. Remote Pharmacy's injectable compounded semaglutide is administered once weekly via subcutaneous injection. All sublingual formats - semaglutide tablets and both tirzepatide options - are administered under the tongue once daily. Patients who want to avoid injections entirely have two sublingual options at the $229.99/month tier and two at the $167/month tier.
The choice between active ingredients, and between injectable and sublingual delivery, is ultimately a clinical one. Remote Pharmacy's physicians make that determination based on each patient's health history, current medications, and goals. Patients already on a GLP-1 program elsewhere can transfer - the intake form includes a field to indicate current medication and dosage. Higher doses cost more than starting doses regardless of format.
How the Program Works: Step-by-Step From Intake to Delivery
The entire process is online. No office visit is required at any point.
Step 1 - Health Questionnaire: Patients complete a secure intake form covering medical history, current medications, weight history, and health goals. That information goes directly to the reviewing physician and forms the basis of the clinical assessment. Patients who submit before 2:00 PM ET may receive same-day approval.
Step 2 - Free Virtual Consultation: A licensed U.S. physician from Beluga Health, P.A. reviews the intake and conducts a virtual consultation through the platform's secure portal. The physician determines clinical eligibility. If appropriate, a prescription is written. Approval is not guaranteed - prescriptions are issued only when the physician determines the treatment is clinically suitable for that patient. Some orders require payment before the consultation; if a patient is not approved, a full refund is issued immediately.
Step 3 - Prescription Fulfillment and Free Shipping: Once a prescription is written, it goes to one of Remote Pharmacy's licensed compounding pharmacy partners for preparation. Shipping is free. Medications requiring refrigeration are shipped with appropriate temperature controls. Delivery takes approximately three to five business days after the prescription ships.
Step 4 - First-Month Provider Check-In: At the end of the first month, a licensed provider follows up to review progress, assess side effects, and adjust dosage if warranted. This check-in is a built-in feature of the program, not optional.
Step 5 - Refills on Demand, No Auto-Renew: Refills are not automatic. Patients request them through the patient portal - Remote Pharmacy recommends doing so about a week and a half before the current supply runs out. There is no penalty for pausing. No recurring charge fires without a patient-initiated request. The 24/7 support team is accessible via phone, email, and live chat throughout treatment, with unlimited secure messaging to clinical staff available in the portal.
Pharmacy Partners, Provider Identity, and What 503A Means for Patients
Two licensed U.S. compounding pharmacies fulfill Remote Pharmacy prescriptions:
Pharmacy Hub - 15600 NW 15th Ave, Miami, FL 33169. Phone: (305) 731-2318. Licensed in all 50 states. Cannot dispense sterile compounds in Louisiana, Mississippi, or New Mexico.
GoGo Meds DBA Jungle Jims - 5484 Dixie Highway, Fairfield, OH 45014. Phone: (877) 858-3784. Licensed in 44 states. Cannot dispense sterile compounds or service California, Delaware, Massachusetts, Mississippi, Nevada, New Hampshire, New Jersey, North Carolina, Texas, or West Virginia.
Remote Pharmacy assigns pharmacies based on availability and may reassign without advance notice. Medication appearance - color, shape, markings - may vary by supplier at the time of fulfillment. Remote Pharmacy's published materials describe its pharmacy partners as 503A-certified facilities. A 503A pharmacy is a state-licensed traditional compounding pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. Under 503A, prescriptions must be patient-specific - they are not manufactured at scale for general distribution. That distinction is the legal basis on which patient-specific GLP-1 compounding currently operates in 2026.
Clinical services are provided by Beluga Health, P.A. c/o Jonah Mink MD, a Florida professional corporation. Office: 1321 Upland Dr., Suite 18399, Houston, TX 77043. Contact: info@belugahealth.com.
Pricing, Insurance, and What to Budget for the Long Term
Remote Pharmacy does not accept commercial insurance, HSA, HRA, or FSA. All treatment is cash-pay. There are no hidden membership fees or subscription charges. The price shown at enrollment covers medication, physician consultation, and shipping.
Published starting prices run $167/month for compounded semaglutide options and $229.99/month for compounded tirzepatide options. Those are starting prices - patients who titrate to higher maintenance doses will pay more. Budget planning should account for dose escalation, which is a normal part of GLP-1 therapy.
Because there is no subscription and no auto-renew, patients control the full cadence of their treatment. Pausing is free. Stopping carries no penalty. Resuming requires a new refill request through the portal.
Eligibility Criteria and State Availability
A licensed physician makes all eligibility determinations. Remote Pharmacy's published guidelines describe the typical eligible patient as an adult with a BMI above the healthy range, an adult with weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol, or an adult who has tried other weight loss approaches without achieving desired results. These are general guidelines - the physician's assessment governs.
Remote Pharmacy ships to most U.S. physical addresses and P.O. Boxes accepting UPS and USPS. Compounded semaglutide is not available for shipment to Mississippi or New Mexico. The platform does not service Puerto Rico, the U.S. Virgin Islands, APO/FPO/DPO addresses, or mail-forwarding services. State-level availability of specific compounded formulations may vary based on which pharmacy is assigned and that pharmacy's current licensure.
Refund and Returns Policy
All prescription product sales are final. Remote Pharmacy does not accept returns of prescription medications for reuse or resale. If a patient believes an error was made in fulfillment, contact Remote Pharmacy at support@remotepharmacy.com or 435-351-2380 as promptly as possible. Orders that have already shipped cannot be canceled. The full Returns and Cancellations policy is at remotepharmacy.com.
Remote Pharmacy Contact Information
Phone: 435-351-2380 (Monday-Friday 8:00 AM-8:00 PM EST; Saturday-Sunday 10:00 AM-7:00 PM EST)
Email: support@remotepharmacy.com (within 24 hours)
Live Chat: Patient portal
Address: Remote Pharmacy, LLC, 261 NE 61st Street, Miami, Florida 33137
Frequently Asked Questions
Is Remote Pharmacy still accepting new patients in 2026?
Yes. As of May 2026, Remote Pharmacy is actively enrolling new patients for its GLP-1 weight loss programs. Current pricing, intake forms, and operating hours are listed at remotepharmacy.com. Program terms may change - patients should verify availability directly before enrolling.
Does Remote Pharmacy accept insurance?
No. Remote Pharmacy does not accept commercial insurance, HSA, HRA, or FSA. All treatment is cash-pay. The published price covers medication, consultation, and shipping with no additional charges layered on top.
Is there a subscription or auto-renew?
No. Remote Pharmacy is not a subscription-based platform. There is no automatic billing, no auto-refill, and no recurring charge. Refills are patient-initiated through the portal. No membership fee is required.
What is the difference between injectable and sublingual formats?
The injectable compounded semaglutide is administered via subcutaneous injection once weekly. All sublingual formats are administered under the tongue once daily. Both deliver the active ingredient - the route and frequency differ. The appropriate format is determined during the physician consultation based on patient preference and clinical suitability.
Can I transfer from another GLP-1 program?
Yes. The intake form includes a field to indicate current GLP-1 medication and dosage. Remote Pharmacy's clinical team determines the appropriate continuation dose. Higher doses are priced higher than starting doses, so patients transferring from a higher-dose program should verify the cost at their current dosage level.
What happens if FDA policy changes and compounded GLP-1s become unavailable?
This is the most important question in the compounded GLP-1 category right now. Remote Pharmacy does not publish a specific contingency plan for FDA-driven compounding disruptions. Patients considering any compounded GLP-1 program - including this one - should understand that availability is subject to FDA policy, pharmacy licensure, and state law, and could change without advance notice. Patients who want maximum long-term continuity certainty may prefer to evaluate platforms offering FDA-approved branded GLP-1 medications when and if those become accessible to them.
How quickly does medication arrive?
Patients who submit their intake before 2:00 PM ET may receive same-day physician approval. After the prescription reaches the pharmacy, medications typically ship within approximately three business days and arrive within three to five business days of shipping.
Does Remote Pharmacy have a LegitScript certification?
LegitScript certification is an independent verification that a telehealth platform or pharmacy meets established compliance standards. Patients can check Remote Pharmacy's current LegitScript status directly at legitscript.com before enrolling.
What if my physician does not approve me?
If payment is required before the consultation and the physician does not approve treatment, a full refund is issued immediately. Prescription approval is never guaranteed.
What if my medication arrives with melted ice packs?
Ice packs are included during warm months. If they have melted on arrival, the medication is still safe to use. Compounded semaglutide has been tested for stability at room temperature for up to 30 days, at 95°F for up to 15 days, and at 107°F for up to four days.
Is my health information secure?
Remote Pharmacy uses 256-bit SSL/TLS encryption. All data handling is governed by its published Privacy Policy and HIPAA Compliance Notice, available at remotepharmacy.com.
Summary: Three Questions to Answer Before You Enroll
Remote Pharmacy is a U.S.-based telehealth platform offering physician-supervised access to compounded GLP-1 weight loss medications through a fully online process. Medical oversight is provided by Beluga Health, P.A. Prescriptions are fulfilled through licensed 503A compounding pharmacies in Miami, FL and Fairfield, OH. Consultations are free. Shipping is free. No subscription. No auto-renew. No hidden fees. Starting prices are clearly published on the platform's weight-loss page at $167/month for compounded semaglutide and $229.99/month for compounded tirzepatide.
Before enrolling in this program or any compounded GLP-1 program, three questions deserve an honest answer.
First: Are you clear on what compounded means? These medications are not FDA-approved finished drug products, not generics, and not interchangeable with brand-name GLP-1 medications. A physician may or may not determine you are a candidate. Approval is never guaranteed.
Second: Are you comfortable with the 2026 regulatory environment? Patient-specific 503A compounding remains legal, but the landscape is more actively scrutinized than it was a year ago. Availability is subject to change. Anyone enrolling in a compounded GLP-1 program today should factor that uncertainty into their decision.
Third: Does the no-subscription, no-auto-renew structure work for your situation? For patients who want full control over refill timing and no recurring commitment, that structure is a genuine practical advantage. For patients who want a managed program with automatic continuity, it requires more active participation.
If the answer to all three is yes, Remote Pharmacy's program offers a physician-supervised path to compounded GLP-1 access with published starting prices clearly listed on its weight-loss page.
Additional Remote Pharmacy Coverage
Remote Pharmacy has been covered across financial and health-focused publications. Additional resources on the platform's GLP-1 program and availability are accessible through previously published availability updates and additional coverage on the platform's telehealth expansion.
This content was produced in connection with a marketing arrangement with Remote Pharmacy. See full terms and conditions at remotepharmacy.com.
FDA Disclaimer: Compounded semaglutide and tirzepatide are not FDA-approved finished drug products, are not generic versions of Ozempic®, Wegovy®, Mounjaro®, or Zepbound®, and have not been reviewed by the FDA for safety, effectiveness, or quality. Compounded medications are prepared by state-licensed pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act. These statements have not been evaluated by the Food and Drug Administration.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a licensed physician before beginning any prescription weight management program. Prescription medications require clinical evaluation and a valid prescription from a licensed healthcare provider.
Results Disclaimer: Weight loss results vary by individual. Results reported in studies of FDA-approved branded GLP-1 medications do not apply to compounded formulations. Remote Pharmacy states that individual outcomes depend on eligibility, dosage, duration, consistency, lifestyle habits, and physician supervision. Extreme or rapid weight loss is not a medically appropriate goal.
Affiliate Disclosure: This article contains affiliate links. If a purchase is made through these links, a commission may be earned at no additional cost to the reader. This compensation does not influence the factual accuracy of the information presented.
Pricing Disclaimer: All pricing reflects published product-level information on Remote Pharmacy's weight-loss page at the time of this overview. Pricing is subject to change. Patients should verify current pricing at remotepharmacy.com before enrolling.
Insurance Disclaimer: Remote Pharmacy does not accept commercial insurance, HSA, HRA, or FSA. All treatment is cash-pay.
Availability Disclaimer: Compounded semaglutide is not available for shipment to Mississippi or New Mexico. Availability of specific compounded formulations may change based on FDA policy, pharmacy licensure, state law, and prescription-specific requirements. Remote Pharmacy does not service Puerto Rico, the U.S. Virgin Islands, APO/FPO/DPO addresses, or mail-forwarding services.
Publisher Responsibility Disclaimer: The publisher of this article has made every effort to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with the official source before making a purchase decision.
SOURCE: Remote Pharmacy
Source: Remote Pharmacy
